Finance

Lists
Q3 2026 earnings • released • EPS miss -17.42%
See results
ETRA:NASDAQ
Electra Therapeutics Inc
$8.84
-2.96%
(-0.27) 1D
Nov 13, 4:00:00 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ETRA...
Open
$9.37
High
$9.37
Low
$7.62
Mkt. cap
555.74M
Avg. vol.
400.14K
Volume
313.15K
52-wk high
$15.50
52-wk low
$6.88
No. of employees
46
Open
$9.37
High
$9.37
Low
$7.62
Mkt. cap
555.74M
Avg. vol.
400.14K
Volume
313.15K
52-wk high
$15.50
52-wk low
$6.88
No. of employees
46
News stories
From web sources and news partners
About Electra Therapeutics Inc
CEO-
Employees46
Founded2018
HeadquartersSouth San Francisco, California, United States
SectorHealth Care
IndustryBiotechnology
Analyst ratings
Based on 5 analysts giving stock ratings to ETRA in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for ETRA in the last 3 months.
Highest
Current $8.84
$36.00 (+307.24%)
Average
$32.67 (+269.57%)
Lowest
$30.00 (+239.37%)
Analyst
Recommendation
Action
Price target
Projected
Date
Cory Kasimov
Evercore ISI
Buy
Maintained
$36.00
+307.2%
11/13/2026
Ram Selvaraju
H.C. Wainwright
Buy
Initiated
$30.00
+239.4%
10/26/2026
Akash Tewari
Jefferies
Buy
Initiated
$32.00
+262%
10/13/2026
Eric Schmidt FCA
Cantor Fitzgerald
Buy
Initiated
-
-
10/13/2026
Tyler Van Buren
TD Cowen
Buy
Initiated
-
-
10/13/2026
Last report
Nov 12, 2026
Fiscal period
Q3 2026
-$3.47 / -$2.96
-17.42%miss
Revenue / Est. (USD)
- / 0.00
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
9.40M
9.40M
20.82M
20.82M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.29M
3.29M
4.30M
4.30M
Operating expense
12.68M
12.68M
25.12M
25.12M
Total operating expenses
12.68M
12.68M
25.12M
25.12M
Operating income
-12.68M
-12.68M
-25.12M
-25.12M
Other non operating income
-
-
-
-
EBT including unusual items
-12.68M
-12.68M
-24.46M
-24.46M
EBT excluding unusual items
-12.68M
-12.68M
-24.46M
-24.46M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-12.68M
-12.68M
-24.46M
-24.46M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
168.50K
168.50K
660.00K
660.00K
Interest expense
-163.50K
-163.50K
-
-
Net interest expenses
5.00K
5.00K
660.00K
660.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-25.05M
-25.05M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps